Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 28, Issue 6 SUPPL. 63, 2010, Pages

  Torrente Segarram, V ^a,b   Abelló, J Carbonell ^a   Oreiro, S Castro ^a   Domínguez, J M Manresa ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Anxiety; Depression; Fibromyalgia; Health status; Systemic lupus erythematosus

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; DEPRESSION; DISEASE ACTIVITY; FEMALE; FIBROMYALGIA; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 12; SYSTEMIC LUPUS ERYTHEMATOSUS; ANXIETY; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FIBROMYALGIA; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79952689339     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ZOMA A: Musculoskeletal involvement in systemic lupus erythematosus. Lupus 2004; 13:851-53.
2. MORAND EF, MILLER MH, WHITTINGHAM S, LITTLEJOHN GO: Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus 1994; 3: 187-91.
3. FRIEDMAN AW, TEW MB, AHN C et al:, for the LUMINA Study Group. Lupus 2003; 12: 274-9.
4. MIDDLETON G, MCFARLIN J, LIPSKY P: The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis & Rheum 1994; 37: 1181-8.
5. HANDA R, AGGARWAL P, WALI JP, WIG N, DWIVEDI SN: Fibromyalgia in Indian patients with systemic lupus erythematosus. Lupus 1998; 7:475-8.
6. NERY FG, BORBA EF, HATCH JP, SOARES JC, BONFÁ E, NETO FL: Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry 2007; 48: 14-9.
7. STOJANOVICH L, ZANDMAN-GODDARD G, PAVLOVICH S, SIKANICH N: Psychiatric manifestations in systemic lupus erythematosus. Autoimmunity Reviews 2007; 6: 421-26.
8. THIEME K, TURK DC, FLOR H: Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med, 2004; 6: 837-44.
9. ARNOLDLM, HUDSON JI, KECK PE, AUCHENBACH MB, JAVARAS KN, HESS EV: Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry, 2006; 8: 1129-5.
10. HUTCHINSON GA, NEHALL JE, SIMEON DT: Psychiatric disorders in systemic lupus erythematosus. West Indian Med J 1996; 45: 48-50.
11. MIGUEL EC1 PEREIRA RMR1 PEREIRA CAB et al:. Psychiatric manifestations of systemic lupus erythematosus: clinical features, symptoms, and signs of central nervous system activity in 43 patients. Medicine 1994; 73: 224-32.
12. BACHEN E, CHESNEY M, CRISWELL A: Prevalence of mood and anxiety disorders in woment with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 822-9.
13. TAN EM, COHEN AS, FRIES JF et al:. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
14. WOLFE F, SMYTHE HA, YUNUS MB et al:. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
15. FREUNDLICH B, LEVENTHAL U: Comment on the 1990 American College of rheumatology criteria for fibromyalgia. Arthritis Rheum 1990; 12: 1863-4.
16. RIVERA J, GONZALEZ T: The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004; 5: 554-60.
17. BENNET R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 5 (Suppl. 39): S154-62.
18. LOBOA,CHAMORRO L, LUQUEA, DAL-RER, BADIA X, BARO E; GRUPO DE VALIDACIÓN EN ESPAÑOL DE ESCALAS PSICOMÉTRICAS (GVEEP): Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin 2002; 13: 493-9.
19. BOBES J, BULBENA A, LUQUE A et al:. A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale. Med Clin 2003; 18: 693-700.
20. GLADMAN DD, GOLDSMITH CH, UROWITZ MB et al:. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol 1994; 8: 1468-71.
21. th edition, Elsevier Saunders, 2005; p.1201-24.
22. VILAGUT G, FERRER M, RAJMIL L et al:. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 2005; 2: 135-50.
23. GLADMAN D, UROWITZ M, FORTIN P et al:. Systemic Lupus International Collaborating Clinics Conference on assessment of lupus flare and Quality of Life measures in SLE. SLICC Group. J Rheumatol 1996; 23: 1953-5.
24. ALONSO J, REGIDOR E, BARRIO G, PRIETO L, RODRIGUEZ C, DE LA FUENTE L: Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36. Med Clin Bare 1998; 111:410-16.
25. GANDEK B, WARE JE, AARONSON NK et al:. Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-8.
26. ESTEVE-VIVES J, BATLLE-GUALDA E, REIG A: Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptación del HAQ a la Poblacion Española. J Rheumatol 1993; 12: 2116-22. English, Spanish.
27. MILLIGAN SE, HOM DL, BALLOU SP, PERSSE U, SVILAR GM, COULTON CJ: An assessment of the health assessment questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 1993; 20: 972-6.
28. TAYLOR-GJEVRE RM, GJEVRE JA: Antiglutamic acid decarboxylase antibodies ina a patient with systemic lupus erythematosus and fibromyalgia symptoms. Lupus 2005; 14: 486-8.
29. MAHLER M, KESSENBROCK K, SZMYRKA M et al.: International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 2006; 13: 77-83.
30. KATZAV A, SOLODEEV I, BRODSKY O et al.: Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007; 56: 938-48.
31. OHIRA H, TAKIGUCHI J, RAI T et al.: High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosusassociated hepatitis. Hepatol Res 2004; 28: 137-9.
32. TAKEDA I, IWADATE H, SUGISAKI K et al.: Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus. Fukushima J Med Sci 2005; 51: 11-8.
33. ZANDMAN-GODDARD G, CHAPMAN J SHOENFELD Y: Autoantibodies involved in neuropsychiatrie SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007; 5: 297-315.
34. MAS AJ, CARMONA L, VALVERDE M, RIBAS B; EPISER STUDY GROUP: Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 2008; 26: 519-26.
35. NÄRING GW, VAN LANKVELD W, GEENEN R: Somatoform dissociation and traumatic experiences in patients with rheumatoid arthritis and fibromyalgia. Clin Exp Rheumatol 2007; 25: 872-7
36. BELT NK, KRONHOLM E, KAUPPI MJ: Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol 2009; 27: 35-41.
37. ABU-SHAKRA M, MADER R, LANGEVITZ P et al.: Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999; 26: 306-9.